Rekombinanter NAPSA Antikörper (AA 50-150)
Kurzübersicht für Rekombinanter NAPSA Antikörper (AA 50-150) (ABIN7875323)
Target
Alle NAPSA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 50-150
-
Verwendungszweck
- Napsin A Antibody (azide and preservative free)
-
Aufreinigung
- Protein A affinity
-
Immunogen
- A recombinant partial protein sequence (within amino acids 50-150) from the human protein was used as the immunogen for the Napsin A antibody.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the Napsin A antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the Napsin A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Andere Bezeichnung
- Napsin A
-
Hintergrund
- Napsin is a pepsin-like aspartic proteinase connected with maturation of surfactant protein B.There are two closely related napsins, napsin A and napsin B. Napsin A is expressed as a single chain protein. Immunohistochemical studies revealed high expression levels of napsin A in human lung and kidney but low expression in spleen. Napsin A is expressed in type II pneumocytes and in adenocarcinomas of lung. The high specificity expression of napsin A in adenocarcinomas of lung is useful to distinguish primary lung adenocarcinomas from adenocarcinomas of other organs.
-
UniProt
- O96009
-
Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Target
-